SOHM
SOHM Inc. is a US public company (OTC Pink: SHMN) operating four units: OTC nutraceuticals, generic pharmaceuticals, CDMO services, and the proprietary ABBIE non-viral gene-editing platform, serving consumers via Amazon/Walmart/Shopify, emerging-market distributors, and biotech partners.
- Company typePublic
- Founded2011
- HeadquartersBuena Park, United States
- Headcount51–100
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What SOHM does
SOHM Inc. is a US-based public company (OTC Pink: SHMN) operating four business units: Nutraceuticals/OTC consumer health products, generic Pharmaceuticals, a Biotech Division built around the proprietary ABBIE gene-editing platform, and CDMO contract manufacturing services. The Nutraceuticals/OTC portfolio includes biotin and multivitamin gummies, turmeric/ginger gummies, Nail Renovar and Nail Renovar Plus antifungal solutions, the FOHM foam face wash, and iProlec nutritional supplements, distributed through Amazon US and UK, Walmart Global Seller, and a Shopify storefront. The Pharmaceutical unit produces generic Levetiracetam for epilepsy across 250mg-1000mg strengths, with exclusive distribution agreements including Stallion Laboratories in India. The Biotech Division is centered on ABBIE (A Binding Based Integrase Enzyme), a Cas9-guided retroviral integrase platform that enables programmable DNA insertion without double-strand breaks or viral vectors, with issued patents in China and pending applications in the US, EU, Japan, and South Korea; preclinical applications include CAR-T cell engineering and the recently announced SKOV3-GYS1 drug-discovery cell line. The CDMO segment offers formulation, testing, packaging, labeling, and global distribution under cGMP, FDA, and EPA licenses from a 5,500 sq ft San Diego facility and a Carlsbad GMP-compliant topical production facility launched in November 2023, with Vista manufacturing and a Tucson R&D presence at the University of Arizona Center for Innovation. Revenue mechanics combine direct-to-consumer retail sales, B2B private-label manufacturing, exclusive distributor agreements in emerging markets (Africa, Latin America, Southeast Asia), and a developing licensing pipeline for ABBIE; Q1 2023 reported revenue was $52,000 with 14% YoY growth.
SOHM firmographics
Firmographics- Name
- SOHM
- Legal name
- SOHM, Inc.
- Website
- https://sohm.com
- Company type
- Public
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- SOHM Inc. is a US public company (OTC Pink: SHMN) operating four units: OTC nutraceuticals, generic pharmaceuticals, CDMO services, and the proprietary ABBIE non-viral gene-editing platform, serving consumers via Amazon/Walmart/Shopify, emerging-market distributors, and biotech partners.
- Ownership category
- akta.pro rank
SOHM industry classification
Industry- Product category
- Pharmaceutical & Nutraceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)
- akta.pro secondary industry
- Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
Keywords
Where SOHM is headquartered
LocationHeadquarters
- HQ city
- Buena Park
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
SOHM business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Pharmaceutical Products: Manufacturing and distribution of generic and branded generic pharmaceuticals including Levetiracetam for seizure control. Products exported globally with focus on emerging markets in Africa, Latin America, and Southeast Asia.
- Nutraceutical and OTC Products: Private label and SOHM-branded nutraceuticals including gummies (biotin, multivitamin, turmeric/ginger), Nail Renovar, Nail Renovar Plus, FOHM face wash, and iProlec supplements sold through Amazon, Walmart, and direct-to-consumer Shopify store.
- CDMO/Contract Manufacturing Services: Contract development and manufacturing organization services for topical drugs, skincare, and pharmaceutical products. Services include formulation development, testing, packaging, and global distribution support for private label customers.
- Gene Editing Technology Licensing: ABBIE platform technology licensing opportunities for research, synthetic biology, and therapeutic applications including CAR-T therapy development and cell engineering.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
SOHM product offering
Product offeringCore offering
SOHM Inc. is a diversified biopharmaceutical and wellness company that develops, manufactures, and distributes generic pharmaceuticals, nutraceuticals, and cosmeceuticals across multiple business units. Its operations span an OTC nutraceutical division (gummy vitamins, hair/skin/nail products), a pharmaceuticals division (generic Levetiracetam tablets and capsules), a biotech division (ABBIE gene editing platform with patented CRISPR-related IP), and a CDMO services unit offering contract development, manufacturing, and private-label services from facilities in Carlsbad and San Diego.
Product overview
SOHM Inc. is a diversified biotechnology company operating across four core business units: Nutraceuticals/OTC, Pharmaceuticals, Biotech Division, and CDMO services. The product portfolio includes: Gummies (Biotin Multivitamin, Multivitamin Multimineral, Turmeric and Ginger), Nail Renovar and Nail Renovar Plus (antifungal treatments), FOHM (cosmeceutical face wash), iProlec (nutritional supplement), Levetiracetam (generic anti-epileptic pharmaceutical), the ABBIE gene editing platform (biotech), and comprehensive CDMO/manufacturing/distribution services. The company operates a 5,500 sq ft FDA-compliant manufacturing facility in San Diego and a GMP-compliant topical production facility in Carlsbad, California.
Differentiator
Problem solved
Functional benefit
Products and services
- Nail Renovar Nail Renovar is a cosmeceutical product for nail health and appearance, sold as part of SOHM's FOHM consumer product line. It is targeted at individual consumers seeking beauty and self-care solutions.
- Nail Renovar Plus Nail Renovar Plus is an upgraded cosmeceutical nail-care product, part of SOHM's FOHM consumer wellness line for nail strengthening and care.
- Biotin Multivitamin Gummies Biotin Multivitamin Gummies are an OTC nutraceutical supplement combining biotin with multivitamins, manufactured and sold by SOHM for consumer health and beauty support.
- Multivitamin Multimineral Gummies Multivitamin Multimineral Gummies are an OTC dietary supplement offering daily nutritional support, sold to individual consumers via SOHM's retail channels.
- Turmeric and Ginger Gummies Turmeric and Ginger Gummies are an OTC nutraceutical supplement combining turmeric and ginger extracts for joint and anti-inflammatory support, sold to consumers.
- Levetiracetam Generic Pharmaceutical Levetiracetam is a generic anti-epileptic pharmaceutical offered by SOHM in tablet and capsule form, manufactured under an FDA-compliant framework and distributed via partners in emerging markets for the treatment of seizures.
- ABBIE Gene Editing Platform The ABBIE Gene Editing Platform is SOHM's proprietary CRISPR-related gene editing technology offered to research institutions, therapeutic developers, and agricultural biotech partners for precise genome editing applications.
- CDMO Services SOHM's CDMO Services provide end-to-end contract development and manufacturing for nutraceutical, cosmeceutical, and pharmaceutical clients, including private-label production, formulation, and packaging from SOHM's FDA-compliant facilities.
Quantifiable outcome
- ABBIE-engineered SKOV3-GYS1 cells showed GYS1 protein levels approximately 3x those of parental cells
- +3 more outcomes
Companies that use SOHM
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
SOHM technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
SOHM partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor, flagship, core and strategic.
- Carlsbad Manufacturing Facility PartnerminorGMP-compliant topical production facility launched in Carlsbad in November 2023 as part of CDMO expansion, though specific manufacturing partner not explicitly named.
- CGA Intellectual Holdings Inc. (Dr. David Aguilar)flagshipLetter of Intent signed to acquire stem cell disruptive technology and patents (ABBIE). Dr. David Aguilar, along with partners, owns CGA Intellectual Holdings which holds patents for ABBIE gene editing technology. Technology previously licensed to develop CAR-T immunotherapies.
- Stallion Laboratories Pvt. Ltd.coreExclusive distribution agreement for Levetiracetam anti-epileptic medication. Stallion Laboratories, an India-based pharmaceutical company, received exclusive rights to distribute SOHM's Levetiracetam product for epilepsy treatment in their market.
- BrainwisecoreSOHM collaborated for commercial manufacturing of Brainwise patented Omega 3 formula for global distribution. This partnership leveraged SOHM's manufacturing capabilities for a proprietary pharmaceutical-grade nutritional supplement.
- Ranbaxy (now part of Sun Pharma)coreSOHM India Pvt. Ltd., an Indian subsidiary of SOHM Inc., entered into an agreement with Ranbaxy for dermatology product distribution. Ranbaxy, one of India's largest pharmaceutical companies, distributed SOHM's dermatology products in the Indian market.
- Coastar TherapeuticsstrategicCollaboration for new delivery systems to minimize immune recognition of engineered proteins in ABBIE-based CAR-T therapies. Strategic partnership for next-generation cellular immunotherapy development.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
SOHM competitors and assessment
Company assessmentDirect peers
- Amphastar Pharmaceuticals: US generic injectables and inhalation pharmaceutical manufacturer with integrated R&D and manufacturing. Comparable generic-pharma manufacturer with vertical integration similar to SOHM's model.
- Lannett Company: Small-cap US generic pharmaceutical manufacturer focused on off-patent molecules with diversified product portfolio. Most directly comparable to SOHM in scale, generic-pharma focus, and public-micro-cap profile.
- ANI Pharmaceuticals: US specialty generics and CDMO player combining in-house manufacturing with contract services. Comparable to SOHM's hybrid generic-pharma + CDMO service model.
- Padagis: Topical and specialty generics manufacturer spun out of Perrigo, focused on off-patent prescription and OTC products. Closely comparable to SOHM's topical generics and OTC portfolio.
Broad incumbents
- Patheon (Thermo Fisher Scientific): Large-scale CDMO services platform within Thermo Fisher offering drug substance, drug product, and biologics manufacturing. Comparable to SOHM's CDMO unit but at global-enterprise scale.
- Catalent: Global CDMO leader offering formulation, manufacturing, and packaging services across dosage forms. Comparable to SOHM's CDMO services unit but at vastly larger scale and broader capability.
- Aurobindo Pharma: India-based global generic pharmaceutical manufacturer with broad portfolio including Levetiracetam. Represents the large-scale competitive force in SOHM's core generic and emerging-market segments.
- Lupin Pharmaceuticals: India-headquartered global generic and specialty pharma company with significant US generics business. Comparable generic-pharma competitor with established manufacturing and emerging-market distribution.
Emerging players
- Beam Therapeutics: Clinical-stage base-editing gene editing company developing precision genetic medicines. Comparable technology adjacency to SOHM's ABBIE non-viral gene editing platform.
- Intellia Therapeutics: Clinical-stage gene editing company developing CRISPR/Cas9-based in vivo and ex vivo therapies. Comparable to SOHM's ABBIE platform ambition but at advanced clinical stage with major partner backing.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
SOHM social profiles
Digital presenceSOHM financial estimates
Financial estimateRevenue estimate
Valuation estimate
SOHM leadership team
Management profileNumber of profiles
Profiles2 records
SOHM subsidiaries and ownership
Company hierarchySubsidiaries1 record
SOHM funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SOHM M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SOHM
What does SOHM do?
SOHM Inc. is a diversified biopharmaceutical and wellness company that develops, manufactures, and distributes generic pharmaceuticals, nutraceuticals, and cosmeceuticals across multiple business units. Its operations span an OTC nutraceutical division (gummy vitamins, hair/skin/nail products), a pharmaceuticals division (generic Levetiracetam tablets and capsules), a biotech division (ABBIE gene editing platform with patented CRISPR-related IP), and a CDMO services unit offering contract development, manufacturing, and private-label services from facilities in Carlsbad and San Diego.
Is SOHM a public or private company?
SOHM is a public company. It is classified as public and is currently operating.
When was SOHM founded?
SOHM was founded in 2011. It employs 51 to 100 people.
Where is SOHM based?
SOHM is headquartered in Buena Park, United States, in the North America region.
How does SOHM make money?
Four revenue lines are on record. Pharmaceutical Products are the primary driver. The others are nutraceutical and OTC Products, CDMO/Contract Manufacturing Services and gene Editing Technology Licensing.
Who are SOHM's main competitors?
Direct peers on record are Amphastar Pharmaceuticals, Lannett Company, ANI Pharmaceuticals and Padagis. Broad incumbents are Patheon (Thermo Fisher Scientific), Catalent, Aurobindo Pharma and Lupin Pharmaceuticals. Emerging players are Beam Therapeutics and Intellia Therapeutics.
Does SOHM have an API?
No public API is recorded for SOHM.
What industry is SOHM in?
SOHM's product category is Pharmaceutical & Nutraceutical Manufacturing. Its primary akta.pro industry code is HLAIABAI, Contract Development & Manufacturing for Generics (CDMO/CMO), with a secondary code of HLAGABAG, Drug Substance–Drug Product Integrated CDMO. Its NAICS code is 325412 and its SIC code is 2834.